OncoResponse

About:

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

Website: https://oncoresponse.com

Twitter/X: OncoResponse

Top Investors: Alexandria Venture Investments, Rice University, ARCH Venture Partners, GreatPoint Ventures, Alexandria Real Estate Equities

Description:

OncoResponse is an immuno-oncology biotech company that is leveraging its proprietary human antibody platform to discover novel targets and identify fully human monoclonal antibodies as therapeutics for the treatment of cancers. It identifies genuine human antibodies to a variety of high-value targets linked with immunosuppressive myeloid biology. OncoResponse's antibody pipeline is expected to alleviate TME immunosuppression and boost immune activation, turning cold tumors hot.